4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid
C152H197N17O15 — CID 157300081
Data last refreshed: (MolForge compound catalog, from PubChem)
IUPAC4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid
SMILESCC(=O)C(C)N1CCC(O)(C(=O)NCCCc2ccc3c(n2)CCCC3)CC1.CC(=O)C(c1ccccc1)N1CCC(O)(C(=O)CCCCc2ccc3c(n2)NCCC3)CC1.CC(=O)[C@@H](c1ccccc1)N1CC(C(=O)CCCCCc2ccc3c(n2)CCCC3)C1.CC(=O)[C@H](c1ccccc1)N1CC(C(=O)CCCCCc2ccc3c(n2)CCCC3)C1.CC(=O)[C@H](c1ccccc1)N1CC(NC(=O)CCCc2ccc3c(n2)NCCC3)C1.O=C(O)C(c1ccccc1)N1CC[C@H](C(=O)NCCCc2ccc3c(n2)CCCC3)C1
InChIInChI=1S/C27H35N3O3.2C27H34N2O2.C25H31N3O3.C24H30N4O2.C22H33N3O3/c1-20(31)25(21-8-3-2-4-9-21)30-18-15-27(33,16-19-30)24(32)12-6-5-11-23-14-13-22-10-7-17-28-26(22)29-23;2*1-20(30)27(22-11-4-2-5-12-22)29-18-23(19-29)26(31)15-7-3-6-13-24-17-16-21-10-8-9-14-25(21)28-24;29-24(26-15-6-10-21-13-12-18-7-4-5-11-22(18)27-21)20-14-16-28(17-20)23(25(30)31)19-8-2-1-3-9-19;1-17(29)23(18-7-3-2-4-8-18)28-15-21(16-28)26-22(30)11-5-10-20-13-12-19-9-6-14-25-24(19)27-20;1-16(17(2)26)25-14-11-22(28,12-15-25)21(27)23-13-5-7-19-10-9-18-6-3-4-8-20(18)24-19/h2-4,8-9,13-14,25,33H,5-7,10-12,15-19H2,1H3,(H,28,29);2*2,4-5,11-12,16-17,23,27H,3,6-10,13-15,18-19H2,1H3;1-3,8-9,12-13,20,23H,4-7,10-11,14-17H2,(H,26,29)(H,30,31);2-4,7-8,12-13,21,23H,5-6,9-11,14-16H2,1H3,(H,25,27)(H,26,30);9-10,16,28H,3-8,11-15H2,1-2H3,(H,23,27)/t;2*27-;20-,23?;23-;/m.1001./s1
InChIKeyBBUIBEUONQBHMS-MTNILCPNSA-N
MW2502.35 g/mol
LogP21.53
Rot. Bonds52
About 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid
4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid (PubChem CID 157300081) has the molecular formula C152H197N17O15 and a molecular weight of 2502.35 g/mol. Its IUPAC name is 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid.
Molecular Properties
| Compound Name | 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid |
|---|---|
| PubChem CID | 157300081 |
| Molecular Formula | C152H197N17O15 |
| Molecular Weight | 2502.35 g/mol |
| Exact Mass | 2500.52 |
| IUPAC Name | 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid |
| SMILES | CC(=O)C(C)N1CCC(O)(C(=O)NCCCc2ccc3c(n2)CCCC3)CC1.CC(=O)C(c1ccccc1)N1CCC(O)(C(=O)CCCCc2ccc3c(n2)NCCC3)CC1.CC(=O)[C@@H](c1ccccc1)N1CC(C(=O)CCCCCc2ccc3c(n2)CCCC3)C1.CC(=O)[C@H](c1ccccc1)N1CC(C(=O)CCCCCc2ccc3c(n2)CCCC3)C1.CC(=O)[C@H](c1ccccc1)N1CC(NC(=O)CCCc2ccc3c(n2)NCCC3)C1.O=C(O)C(c1ccccc1)N1CC[C@H](C(=O)NCCCc2ccc3c(n2)CCCC3)C1 |
| InChI | InChI=1S/C27H35N3O3.2C27H34N2O2.C25H31N3O3.C24H30N4O2.C22H33N3O3/c1-20(31)25(21-8-3-2-4-9-21)30-18-15-27(33,16-19-30)24(32)12-6-5-11-23-14-13-22-10-7-17-28-26(22)29-23;2*1-20(30)27(22-11-4-2-5-12-22)29-18-23(19-29)26(31)15-7-3-6-13-24-17-16-21-10-8-9-14-25(21)28-24;29-24(26-15-6-10-21-13-12-18-7-4-5-11-22(18)27-21)20-14-16-28(17-20)23(25(30)31)19-8-2-1-3-9-19;1-17(29)23(18-7-3-2-4-8-18)28-15-21(16-28)26-22(30)11-5-10-20-13-12-19-9-6-14-25-24(19)27-20;1-16(17(2)26)25-14-11-22(28,12-15-25)21(27)23-13-5-7-19-10-9-18-6-3-4-8-20(18)24-19/h2-4,8-9,13-14,25,33H,5-7,10-12,15-19H2,1H3,(H,28,29);2*2,4-5,11-12,16-17,23,27H,3,6-10,13-15,18-19H2,1H3;1-3,8-9,12-13,20,23H,4-7,10-11,14-17H2,(H,26,29)(H,30,31);2-4,7-8,12-13,21,23H,5-6,9-11,14-16H2,1H3,(H,25,27)(H,26,30);9-10,16,28H,3-8,11-15H2,1-2H3,(H,23,27)/t;2*27-;20-,23?;23-;/m.1001./s1 |
| InChIKey | BBUIBEUONQBHMS-MTNILCPNSA-N |
| XLogP | 21.53 |
| TPSA | 422.46 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 28 |
| Rotatable Bonds | 52 |
| Heavy Atoms | 184 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2502.35 |
| LogP ≤ 5 | 21.53 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 28 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
What is the IUPAC name of 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid?
The IUPAC name of 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid (CID 157300081) is 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid.
What is the SMILES notation for 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid?
The canonical SMILES for 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid is CC(=O)C(C)N1CCC(O)(C(=O)NCCCc2ccc3c(n2)CCCC3)CC1.CC(=O)C(c1ccccc1)N1CCC(O)(C(=O)CCCCc2ccc3c(n2)NCCC3)CC1.CC(=O)[C@@H](c1ccccc1)N1CC(C(=O)CCCCCc2ccc3c(n2)CCCC3)C1.CC(=O)[C@H](c1ccccc1)N1CC(C(=O)CCCCCc2ccc3c(n2)CCCC3)C1.CC(=O)[C@H](c1ccccc1)N1CC(NC(=O)CCCc2ccc3c(n2)NCCC3)C1.O=C(O)C(c1ccccc1)N1CC[C@H](C(=O)NCCCc2ccc3c(n2)CCCC3)C1.
What is the InChIKey of 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid?
The InChIKey is BBUIBEUONQBHMS-MTNILCPNSA-N. The full InChI is InChI=1S/C27H35N3O3.2C27H34N2O2.C25H31N3O3.C24H30N4O2.C22H33N3O3/c1-20(31)25(21-8-3-2-4-9-21)30-18-15-27(33,16-19-30)24(32)12-6-5-11-23-14-13-22-10-7-17-28-26(22)29-23;2*1-20(30)27(22-11-4-2-5-12-22)29-18-23(19-29)26(31)15-7-3-6-13-24-17-16-21-10-8-9-14-25(21)28-24;29-24(26-15-6-10-21-13-12-18-7-4-5-11-22(18)27-21)20-14-16-28(17-20)23(25(30)31)19-8-2-1-3-9-19;1-17(29)23(18-7-3-2-4-8-18)28-15-21(16-28)26-22(30)11-5-10-20-13-12-19-9-6-14-25-24(19)27-20;1-16(17(2)26)25-14-11-22(28,12-15-25)21(27)23-13-5-7-19-10-9-18-6-3-4-8-20(18)24-19/h2-4,8-9,13-14,25,33H,5-7,10-12,15-19H2,1H3,(H,28,29);2*2,4-5,11-12,16-17,23,27H,3,6-10,13-15,18-19H2,1H3;1-3,8-9,12-13,20,23H,4-7,10-11,14-17H2,(H,26,29)(H,30,31);2-4,7-8,12-13,21,23H,5-6,9-11,14-16H2,1H3,(H,25,27)(H,26,30);9-10,16,28H,3-8,11-15H2,1-2H3,(H,23,27)/t;2*27-;20-,23?;23-;/m.1001./s1.
What are the key properties of 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid?
4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid has a molecular weight of 2502.35 g/mol, XLogP of 21.53, 52 rotatable bonds, 8 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid is sourced from PubChem (CID 157300081), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157300081 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.